Table 1

Lack of CD114 expression distinguishes bona fide HSC from transiently reconstituting multilineage progenitors

TimeSubfractionEngraftNo EngraftStatistic
Week 6 CD114neg/lo 10 0.21 
 CD114pos  
Week 14 CD114neg/lo 12 0.002 
 CD114hi  
TimeSubfractionEngraftNo EngraftStatistic
Week 6 CD114neg/lo 10 0.21 
 CD114pos  
Week 14 CD114neg/lo 12 0.002 
 CD114hi  

The presence of human engraftment in the bone marrow of NOD/SCID/IL-2Rγnull (NSG) mice transplanted with either CD114neg/lo or CD114pos subfractions of the human HSC compartment was determined 6 and 14 weeks after transplantation. No statistically significant difference in engraftment was observed at 6 weeks; however, by 14 weeks, engraftment was markedly enriched in the CD114neg/lo subfraction. The Fisher exact, 2-tailed test was used for statistic calculation.

Close Modal

or Create an Account

Close Modal
Close Modal